P615 Clinical efficacy of accelerated 4-weekly vs. Conventional 8-weekly ustekinumab dosing in Inflammatory Bowel Disease: A single centre experience
Andrew R. Lloyd(Oregon Health & Science University), Jane McCarthy(Mercy University Hospital), Gareth K. Forde(Mercy University Hospital), Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Martin Buckley(Mercy University Hospital), Catherine M. McDonald(Mercy University Hospital), Conor O’Sullivan, K Sugrue(Mercy University Hospital), S Quarry(University College Cork), Carthage Moran(University College Cork), Sarah Gleeson(Mercy University Hospital), G O'Sullivan(Mercy University Hospital), Donal Sheehan(University of Vienna), Melissa Doyle(Royal Children's Hospital)
Cited by 0
Related Papers
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
|BMJ|2006|845
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
|Journal of Crohn s and Colitis|2021|540
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution
|BMC Health Services Research|2003|488